Cargando…

In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model

BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Luce, Eléanor, Steichen, Clara, Allouche, Mickaël, Messina, Antonietta, Heslan, Jean‐Marie, Lambert, Thierry, Weber, Anne, Nguyen, Tuan Huy, Christophe, Olivier, Dubart‐Kupperschmitt, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299628/
https://www.ncbi.nlm.nih.gov/pubmed/34687060
http://dx.doi.org/10.1002/hep.32211
_version_ 1784751018098032640
author Luce, Eléanor
Steichen, Clara
Allouche, Mickaël
Messina, Antonietta
Heslan, Jean‐Marie
Lambert, Thierry
Weber, Anne
Nguyen, Tuan Huy
Christophe, Olivier
Dubart‐Kupperschmitt, Anne
author_facet Luce, Eléanor
Steichen, Clara
Allouche, Mickaël
Messina, Antonietta
Heslan, Jean‐Marie
Lambert, Thierry
Weber, Anne
Nguyen, Tuan Huy
Christophe, Olivier
Dubart‐Kupperschmitt, Anne
author_sort Luce, Eléanor
collection PubMed
description BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, other applications such as drug screening, toxicological studies, or bioartificial livers are reliant on hepatocyte functionality and require full differentiation of hepatocytes. New technologies have been used to improve the differentiation process in recent years, usually evaluated by measuring the albumin production and CYP450 activity. Here we used the complex production and most importantly the activity of the coagulation factor IX (FIX) produced by mature hepatocytes to assess the differentiation of hemophilia B (HB) patient’s induced pluripotent stem cells (iPSCs) in both monolayer culture and organoids. APPROACH AND RESULTS: Indeed, HB is an X‐linked monogenic disease due to an impaired activity of FIX synthesized by hepatocytes in the liver. We have developed an in vitro model of HB hepatocytes using iPSCs generated from fibroblasts of a severe HB patient. We used CRISPR/Cas9 technology to target the genomic insertion of a coagulation factor 9 minigene bearing the Padua mutation to enhance FIX activity. Noncorrected and corrected iPSCs were differentiated into hepatocytes under both two‐dimensional and three‐dimensional differentiation protocols and deciphered the production of active FIX in vitro. Finally, we assessed the therapeutic efficacy of this approach in vivo using a mouse model of HB. CONCLUSIONS: Functional FIX, whose post‐translational modifications only occur in fully mature hepatocytes, was only produced in corrected iPSCs differentiated in organoids. Immunohistochemistry analyses of mouse livers indicated a good cell engraftment, and the FIX activity detected in the plasma of transplanted animals confirmed rescue of the bleeding phenotype.
format Online
Article
Text
id pubmed-9299628
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92996282022-07-21 In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model Luce, Eléanor Steichen, Clara Allouche, Mickaël Messina, Antonietta Heslan, Jean‐Marie Lambert, Thierry Weber, Anne Nguyen, Tuan Huy Christophe, Olivier Dubart‐Kupperschmitt, Anne Hepatology Original Articles BACKGROUND AND AIMS: Pluripotent stem cell–derived hepatocytes differentiated in monolayer culture are known to have more fetal than adult hepatocyte characteristics. If numerous studies tend to show that this immature phenotype might not necessarily be an obstacle to their use in transplantation, other applications such as drug screening, toxicological studies, or bioartificial livers are reliant on hepatocyte functionality and require full differentiation of hepatocytes. New technologies have been used to improve the differentiation process in recent years, usually evaluated by measuring the albumin production and CYP450 activity. Here we used the complex production and most importantly the activity of the coagulation factor IX (FIX) produced by mature hepatocytes to assess the differentiation of hemophilia B (HB) patient’s induced pluripotent stem cells (iPSCs) in both monolayer culture and organoids. APPROACH AND RESULTS: Indeed, HB is an X‐linked monogenic disease due to an impaired activity of FIX synthesized by hepatocytes in the liver. We have developed an in vitro model of HB hepatocytes using iPSCs generated from fibroblasts of a severe HB patient. We used CRISPR/Cas9 technology to target the genomic insertion of a coagulation factor 9 minigene bearing the Padua mutation to enhance FIX activity. Noncorrected and corrected iPSCs were differentiated into hepatocytes under both two‐dimensional and three‐dimensional differentiation protocols and deciphered the production of active FIX in vitro. Finally, we assessed the therapeutic efficacy of this approach in vivo using a mouse model of HB. CONCLUSIONS: Functional FIX, whose post‐translational modifications only occur in fully mature hepatocytes, was only produced in corrected iPSCs differentiated in organoids. Immunohistochemistry analyses of mouse livers indicated a good cell engraftment, and the FIX activity detected in the plasma of transplanted animals confirmed rescue of the bleeding phenotype. John Wiley and Sons Inc. 2021-12-12 2022-04 /pmc/articles/PMC9299628/ /pubmed/34687060 http://dx.doi.org/10.1002/hep.32211 Text en © 2021 The Authors. Hepatology published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
Luce, Eléanor
Steichen, Clara
Allouche, Mickaël
Messina, Antonietta
Heslan, Jean‐Marie
Lambert, Thierry
Weber, Anne
Nguyen, Tuan Huy
Christophe, Olivier
Dubart‐Kupperschmitt, Anne
In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title_full In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title_fullStr In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title_full_unstemmed In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title_short In vitro recovery of FIX clotting activity as a marker of highly functional hepatocytes in a hemophilia B iPSC model
title_sort in vitro recovery of fix clotting activity as a marker of highly functional hepatocytes in a hemophilia b ipsc model
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299628/
https://www.ncbi.nlm.nih.gov/pubmed/34687060
http://dx.doi.org/10.1002/hep.32211
work_keys_str_mv AT luceeleanor invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT steichenclara invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT allouchemickael invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT messinaantonietta invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT heslanjeanmarie invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT lambertthierry invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT weberanne invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT nguyentuanhuy invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT christopheolivier invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel
AT dubartkupperschmittanne invitrorecoveryoffixclottingactivityasamarkerofhighlyfunctionalhepatocytesinahemophiliabipscmodel